Stories > Novo's Weight-Loss Pill Launch Challenges

Novo's Weight-Loss Pill Launch Challenges

Adcetris Boosts Lymphoma Patients' Survi...

Biobetter Market's Growth Projection

Biopharma Companies Announce Public Offe...

Acquisition Progress Amid Safety Concern

BMY Expands Portfolio with RayzeBio Acqu...

Biden's $35 Insulin Price Cap